Neuren Pharmaceuticals Limited(ASX:NEU) dropped from S&P/ASX Emerging Companies Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.67 AUD | +0.82% | -5.07% | -21.23% |
Feb. 29 | Neuren Pharmaceuticals Limited Provides Sales Guidance for the First Quarter and Full Year 2024 | CI |
Feb. 29 | Transcript : Neuren Pharmaceuticals Limited, Q4 2023 Earnings Call, Feb 29, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.23% | 1.6B | |
+28.79% | 676B | |
+24.77% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.23% | 210B | |
-0.21% | 204B | |
-9.53% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited(ASX: NEU) dropped from S&P/ASX Emerging Companies Index